J. Alberto et al., Clinical course, microbiologic profile, and diagnosis of periannular complications in prosthetic valve endocarditis, AM J CARD, 83(7), 1999, pp. 1075-1079
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Whether periannular extension of prosthetic valve endocarditis (abscesses,
pseudoaneurysms, fistulas) is related to the etiologic agent, the clinical
course and the prognosis is still unknown. Likewise, transesophageal echoca
rdiographic accuracy In detecting periannular complications in prosthetic r
ecipients remains unsettled. We retrospectively analyzed data from 87 patie
nts with anatomically proven prosthetic valve endocarditis who underwent a
transesophageal echocardiographic examination. Periannular complications (3
0 abscesses, 18 pseudoaneurysms, 8 fistulas; 8 with >1) were found in 46 pa
tients; results were compared with the remaining 41 without complications.
Transesophageal echocardiography correctly identified 27 abscesses (90%) an
d all pseudoaneurysms and fistulas. One diagnosis of pseudoaneurysm by echo
cardiography was not found at surgery. No statistical differences were foun
d regarding age, sex, type of prosthesis (mechanical vs biologic), and etio
logic agent. Periannular complications were more frequent in aortic locatio
n (70% vs 20% in mitral position; p < 0.001) and in early (within 6 months
after surgery) endocarditis (63% vs 38% in late endocarditis; p = 0.04). Th
e same percentage of patients from both groups underwent surgery (98% with
and 90% without complications). At discharge, 62% and 67% of patients were
alive, respectively. Thus, periannular complications in prosthetic valve en
docarditis are more frequent in aortic location and within 6 months after s
urgery. Neither the type of prosthesis nor the etiologic agent are related
to the presence of periannular complications. Short-term prognosis in patie
nts who underwent surgery is not affected by the presence of periannular co
mplications. (C) 1999 by Excerpta Medica, Inc.